CA
CDMO

Clearstead Advisors’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Clearstead Advisors’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-40
Closed -$1K – 1394
2022
Q3 		$1K Hold
40
– – ﹤0.01% 1223
2022
Q2 		$1K Hold
40
– – ﹤0.01% 1246
2022
Q1 		$1K Hold
40
– – ﹤0.01% 1343
2021
Q4 		$1K Buy
+40
New +$1.15K ﹤0.01% 1235

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Clearstead Advisors's CDMO Position: Q4 2022 in Review

Clearstead Advisors sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2022, closing a stake of 40 shares — an estimated $1K sold.

Clearstead Advisors first reported a position in CDMO in Q4 2021 and held it in 4 quarters. The position peaked at $1K in Q3 2022. 168 funds tracked by Wall St. Rank hold CDMO as of Q4 2022.

  • Clearstead Advisors reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Clearstead Advisors sold 40 Avid Bioservices, Inc. Common Stock shares in Q4 2022, an estimated $1K.
  • Clearstead Advisors first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2021 and held it in 4 quarters.
  • Clearstead Advisors's Avid Bioservices, Inc. Common Stock position peaked at $1K in Q3 2022.
  • 168 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2022.

Based on Clearstead Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.